1. Home
  2. IOVA vs CDNL Comparison

IOVA vs CDNL Comparison

Compare IOVA & CDNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$3.53

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

CDNL

Cardinal Infrastructure Group Inc. Class A Common Stock

N/A

Current Price

$33.61

Market Cap

980.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IOVA
CDNL
Founded
2007
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
980.9M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
IOVA
CDNL
Price
$3.53
$33.61
Analyst Decision
Buy
Strong Buy
Analyst Count
12
3
Target Price
$10.45
$33.00
AVG Volume (30 Days)
9.3M
204.4K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
32.28
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$60.04
$40.03
Revenue Next Year
$58.54
$18.27
P/E Ratio
N/A
$0.01
Revenue Growth
N/A
N/A
52 Week Low
$1.64
$21.98
52 Week High
$5.64
$35.73

Technical Indicators

Market Signals
Indicator
IOVA
CDNL
Relative Strength Index (RSI) 77.86 73.10
Support Level $2.11 $23.02
Resistance Level $3.73 N/A
Average True Range (ATR) 0.19 2.33
MACD 0.09 1.03
Stochastic Oscillator 97.56 83.19

Price Performance

Historical Comparison
IOVA
CDNL

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About CDNL Cardinal Infrastructure Group Inc. Class A Common Stock

Cardinal Infrastructure Group Inc provides a comprehensive suite of infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. Its operations leverage a large highly skilled workforce and a fleet of specialized equipment to deliver wet utility installations (water, sewer, and stormwater systems), as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services.

Share on Social Networks: